Publication | Open Access

Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections

Drug RepositioningAntibioticsMedicineAntibiotic AdjuvantHealthcare-associated InfectionProspective Antimicrobial AgentAntimicrobial ChemotherapyAntimicrobial CompoundInfection ControlSevere Staphylococcal InfectionsPharmacologyAntimicrobial ResistanceDrug Resistance